Source link : https://newshealth.biz/health-news/fda-approves-icotrokinra-for-moderate-to-severe-psoriasis/
This is the first IL-23 receptor-targeted oral peptide pill, and it is also being evaluated as a treatment for psoriatic arthritis, ulcerative colitis, and Crohn’s disease. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fda-approves-icotrokinra-moderate-severe-plaque-psoriasis-2026a10008c8?src=rss Author : Publish date : 2026-03-18 18:15:00 Copyright for syndicated content belongs to the linked Source.
The post FDA Approves Icotrokinra for Moderate-to-Severe Psoriasis first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-18 18:15:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8